BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35846294)

  • 1. Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.
    Duval V; Alayrac P; Silvestre JS; Levoye A
    Front Endocrinol (Lausanne); 2022; 13():906586. PubMed ID: 35846294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked.
    Koch C; Engele J
    Mol Pharmacol; 2020 Nov; 98(5):577-585. PubMed ID: 32883765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.
    Quinn KE; Mackie DI; Caron KM
    Cytokine; 2018 Sep; 109():17-23. PubMed ID: 29903572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
    Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
    J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate.
    Murad HAS; Rafeeq MM; Alqurashi TMA
    Ann Med; 2021 Dec; 53(1):1598-1612. PubMed ID: 34494495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
    Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
    J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.
    Montpas N; St-Onge G; Nama N; Rhainds D; Benredjem B; Girard M; Hickson G; Pons V; Heveker N
    J Biol Chem; 2018 Jan; 293(3):893-905. PubMed ID: 29180449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.
    Freitas C; Desnoyer A; Meuris F; Bachelerie F; Balabanian K; Machelon V
    Cytokine Growth Factor Rev; 2014 Jun; 25(3):307-16. PubMed ID: 24853339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a chimeric chemokine as a specific ligand for ACKR3.
    Ameti R; Melgrati S; Radice E; Cameroni E; Hub E; Thelen S; Rot A; Thelen M
    J Leukoc Biol; 2018 Aug; 104(2):391-400. PubMed ID: 29601107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α
    Albee LJ; Eby JM; Tripathi A; LaPorte HM; Gao X; Volkman BF; Gaponenko V; Majetschak M
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin.
    Saaber F; Schütz D; Miess E; Abe P; Desikan S; Ashok Kumar P; Balk S; Huang K; Beaulieu JM; Schulz S; Stumm R
    Cell Rep; 2019 Feb; 26(6):1473-1488.e9. PubMed ID: 30726732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.
    Szpakowska M; Nevins AM; Meyrath M; Rhainds D; D'huys T; Guité-Vinet F; Dupuis N; Gauthier PA; Counson M; Kleist A; St-Onge G; Hanson J; Schols D; Volkman BF; Heveker N; Chevigné A
    Br J Pharmacol; 2018 May; 175(9):1419-1438. PubMed ID: 29272550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists.
    Szpakowska M; Meyrath M; Reynders N; Counson M; Hanson J; Steyaert J; Chevigné A
    Biochem Pharmacol; 2018 Jul; 153():299-309. PubMed ID: 29530506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12.
    Del Molino Del Barrio I; Wilkins GC; Meeson A; Ali S; Kirby JA
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30441765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.
    Gustavsson M; Dyer DP; Zhao C; Handel TM
    Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
    Szpakowska M; Dupuis N; Baragli A; Counson M; Hanson J; Piette J; Chevigné A
    Biochem Pharmacol; 2016 Aug; 114():14-21. PubMed ID: 27238288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical Chemokine Receptor 3 Generates Guidance Cues for CXCL12-Mediated Endothelial Cell Migration.
    Tobia C; Chiodelli P; Barbieri A; Buraschi S; Ferrari E; Mitola S; Borsani G; Guerra J; Presta M
    Front Immunol; 2019; 10():1092. PubMed ID: 31156639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology.
    Chatterjee M
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function.
    Smit MJ; van Muijlwijk-Koezen JE
    Mol Pharmacol; 2019 Dec; 96(6):735-736. PubMed ID: 31624136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
    Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
    PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.